Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Tumor classification of six common cancer types based on proteomic profiling by MALDI imaging.
J. Proteome Res. 11, 1996-2003 (2012)
In clinical diagnostics, it is of outmost importance to correctly identify the source of a metastatic tumor, especially if no apparent primary tumor is present. Tissue-based proteomics might allow correct tumor classification. As a result, we performed MALDI imaging to generate proteomic signatures for different tumors. These signatures were used to classify common cancer types. At first, a cohort comprised of tissue samples from six adenocarcinoma entities located at different organ sites (esophagus, breast, colon, liver, stomach, thyroid gland, n = 171) was classified using two algorithms for a training and test set. For the test set, Support Vector Machine and Random Forest yielded overall accuracies of 82.74 and 81.18%, respectively. Then, colon cancer liver metastasis samples (n = 19) were introduced into the classification. The liver metastasis samples could be discriminated with high accuracy from primary tumors of colon cancer and hepatocellular carcinoma. Additionally, colon cancer liver metastasis samples could be successfully classified by using colon cancer primary tumor samples for the training of the classifier. These findings demonstrate that MALDI imaging-derived proteomic classifiers can discriminate between different tumor types at different organ sites and in the same site.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Times Cited
Scopus
Cited By
Cited By
Altmetric
5.113
1.252
93
106
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Schlagwörter
proteomic classifier; tumor classification; proteomic classification; CUP classification; tumor diagnosis; MALDI imaging; MALDI-IMS; MALDI-MSI; imaging MS; GENE-EXPRESSION SIGNATURES; CHAIN-REACTION ASSAY; UNKNOWN PRIMARY CUP; MASS-SPECTROMETRY; BREAST-CANCER; MOLECULAR CLASSIFICATION; HEPATOCELLULAR-CARCINOMA; TISSUE; ADENOCARCINOMA; PATTERNS
Sprache
Veröffentlichungsjahr
2012
HGF-Berichtsjahr
2012
ISSN (print) / ISBN
1535-3893
e-ISSN
1535-3907
Zeitschrift
Journal of Proteome Research
Quellenangaben
Band: 11,
Heft: 3,
Seiten: 1996-2003
Verlag
American Chemical Society (ACS)
Begutachtungsstatus
Peer reviewed
Institut(e)
Research Unit Analytical Pathology (AAP)
Institute of Pathology (PATH)
Translational Metabolic Oncology (IDC-TMO)
Institute of Pathology (PATH)
Translational Metabolic Oncology (IDC-TMO)
POF Topic(s)
30205 - Bioengineering and Digital Health
30504 - Mechanisms of Genetic and Environmental Influences on Health and Disease
30203 - Molecular Targets and Therapies
30504 - Mechanisms of Genetic and Environmental Influences on Health and Disease
30203 - Molecular Targets and Therapies
Forschungsfeld(er)
Enabling and Novel Technologies
Radiation Sciences
Radiation Sciences
PSP-Element(e)
G-500390-001
G-500300-001
G-501000-001
G-500300-001
G-501000-001
PubMed ID
22224404
WOS ID
WOS:000300916200052
Scopus ID
84857824513
Erfassungsdatum
2012-04-20